Professor Hannah Batchelor specialises in developing medicines tailored to the needs of children, with a particular focus on ageappropriate formulations, biorelevant dissolution testing, and the application of cyberphysical systems to transform drug product development. Drawing on experience across academia, the NHS, and the pharmaceutical industry, her work bridges fundamental science with realworld patient needs.

She is currently Professor at the Strathclyde Institute of Pharmacy and Biomedical Sciences, where she leads research on improving the design, manufacture, and performance prediction of paediatric medicines. 

Her contributions influence regulatory guidance, industrial practice, and global initiatives to enhance medicine acceptability and effectiveness for children.